Screening a library of FDA-approved and bioactive compounds for antiviral activity against SARS-CoV-2

SB Biering, E Van Dis, E Wehri… - ACS infectious …, 2021 - ACS Publications
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of
coronavirus disease 2019 (COVID-19), has emerged as a major global health threat. The …
被引用次数：26 相关文章

Screening a library of FDA-approved and bioactive compounds for antiviral activity against SARS-CoV-2

SB Biering, E Van Dis, E Wehri, LH Yamashiro… - 2020 - pesquisa.bvsalud.org
Screening a library of FDA-approved and bioactive compounds for antiviral activity against
SARS-CoV-2 | PREPRINT-BIORXIV loading 1 2 3 +A A -A 3.Screening a library of FDA-approved …

Screening a Library of FDA-Approved and Bioactive Compounds for Antiviral Activity against SARS-CoV‑2

SB Biering, E Van Dis, E Wehri… - ACS Infectious …, 2021 - escholarship.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of
coronavirus disease 2019 (COVID-19), has emerged as a major global health threat. The …

Screening a Library of FDA-Approved and Bioactive Compounds for Antiviral Activity against SARS-CoV-2.

SB Biering, E Van Dis, E Wehri… - ACS Infectious …, 2021 - europepmc.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of
coronavirus disease 2019 (COVID-19), has emerged as a major global health threat. The …

Screening a Library of FDA-Approved and Bioactive Compounds for Antiviral Activity against SARS-CoV-2

SB Biering, E Van Dis, LH Yamashiro… - ACS infectious …, 2021 - oak.novartis.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of
coronavirus disease 2019 (COVID-19), has emerged as a major global health threat. The …

Screening a library of FDA-approved and bioactive compounds for antiviral activity against SARS-CoV-2

SB Biering, E Van Dis, E Wehri, LH Yamashiro… - bioRxiv, 2020 - biorxiv.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of
coronavirus disease 2019 (COVID-19), has emerged as a major global health threat. The …
[PDF] archive.org

[PDF][PDF] Screening a library of FDA-approved and bioactive compounds for antiviral activity against SARS-CoV-2

SB Biering, E Van Dis, E Wehri, LH Yamashiro… - scholar.archive.org
Screening a library of FDA-approved and bioactive compounds for antiviral activity against
SARS-CoV-2 Page 1 1 Screening a library of FDA-approved and bioactive compounds for …

Screening a Library of FDA-Approved and Bioactive Compounds for Antiviral Activity against SARS-CoV-2

SB Biering, E Van Dis, E Wehri… - ACS infectious …, 2021 - pubmed.ncbi.nlm.nih.gov
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of
coronavirus disease 2019 (COVID-19), has emerged as a major global health threat. The …
[PDF] researchgate.net

[PDF][PDF] Screening a library of FDA-approved and bioactive compounds for antiviral activity against SARS-CoV-2

SB Biering, E Van Dis, E Wehri, LH Yamashiro… - researchgate.net
Screening a library of FDA-approved and bioactive compounds for antiviral activity against
SARS-CoV-2 Page 1 1 Screening a library of FDA-approved and bioactive compounds for …

Screening a Library of FDA-Approved and Bioactive Compounds for Antiviral Activity against SARS-CoV-2

SB Biering, E Van Dis, LH Yamashiro… - ACS infectious …, 2021 - oak.novartis.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of
coronavirus disease 2019 (COVID-19), has emerged as a major global health threat. The …